[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

IT1301679B1 - Derivati dell'iperforina, loro uso e formulazioni che licontengono. - Google Patents

Derivati dell'iperforina, loro uso e formulazioni che licontengono.

Info

Publication number
IT1301679B1
IT1301679B1 IT1998MI001312A ITMI981312A IT1301679B1 IT 1301679 B1 IT1301679 B1 IT 1301679B1 IT 1998MI001312 A IT1998MI001312 A IT 1998MI001312A IT MI981312 A ITMI981312 A IT MI981312A IT 1301679 B1 IT1301679 B1 IT 1301679B1
Authority
IT
Italy
Prior art keywords
derivatives
hyperphorine
formulations
contain
glicoside
Prior art date
Application number
IT1998MI001312A
Other languages
English (en)
Inventor
Ezio Bombardelli
Paolo Morazzoni
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to IT1998MI001312A priority Critical patent/IT1301679B1/it
Application filed by Indena Spa filed Critical Indena Spa
Priority to SI9930840T priority patent/SI1086071T1/sl
Priority to PL99344696A priority patent/PL195797B1/pl
Priority to EP99926516A priority patent/EP1086071B1/en
Priority to DE69927813T priority patent/DE69927813T2/de
Priority to AT99926516T priority patent/ATE307103T1/de
Priority to ES99926516T priority patent/ES2249893T3/es
Priority to IL14015199A priority patent/IL140151A0/xx
Priority to JP2000553398A priority patent/JP4511726B2/ja
Priority to CA002334308A priority patent/CA2334308C/en
Priority to SK1871-2000A priority patent/SK286049B6/sk
Priority to EP05015870A priority patent/EP1607099A1/en
Priority to MXPA00012177A priority patent/MXPA00012177A/es
Priority to RU2000131214/04A priority patent/RU2240304C2/ru
Priority to KR1020007013866A priority patent/KR100627933B1/ko
Priority to AU43739/99A priority patent/AU763889B2/en
Priority to BRPI9910893-3B1A priority patent/BR9910893B1/pt
Priority to CNB998071218A priority patent/CN1246278C/zh
Priority to DK99926516T priority patent/DK1086071T3/da
Priority to CZ20004562A priority patent/CZ298859B6/cs
Priority to HU0102226A priority patent/HUP0102226A3/hu
Priority to PCT/EP1999/003880 priority patent/WO1999064388A1/en
Publication of ITMI981312A1 publication Critical patent/ITMI981312A1/it
Publication of IT1301679B1 publication Critical patent/IT1301679B1/it
Application granted granted Critical
Priority to IL140151A priority patent/IL140151A/en
Priority to NO20006230A priority patent/NO328444B1/no
Priority to US09/730,536 priority patent/US6656510B2/en
Priority to HK01107738A priority patent/HK1036791A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/647—Unsaturated compounds containing a keto groups being part of a ring having unsaturation outside the ring
    • C07C49/653—Unsaturated compounds containing a keto groups being part of a ring having unsaturation outside the ring polycyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/013—Esters of alcohols having the esterified hydroxy group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/734—Ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
    • C07C69/84—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring
    • C07C69/92—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring with etherified hydroxyl groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Steroid Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
IT1998MI001312A 1998-06-10 1998-06-10 Derivati dell'iperforina, loro uso e formulazioni che licontengono. IT1301679B1 (it)

Priority Applications (26)

Application Number Priority Date Filing Date Title
IT1998MI001312A IT1301679B1 (it) 1998-06-10 1998-06-10 Derivati dell'iperforina, loro uso e formulazioni che licontengono.
HU0102226A HUP0102226A3 (en) 1998-06-10 1999-06-04 Hyperforin derivatives, the use thereof and formulations containing them
EP99926516A EP1086071B1 (en) 1998-06-10 1999-06-04 Hyperforin derivatives, the use thereof and formulations containing them
DE69927813T DE69927813T2 (de) 1998-06-10 1999-06-04 Hyperforin-derivate, ihre verwendung sowie diese enthaltende zubereitungen
AT99926516T ATE307103T1 (de) 1998-06-10 1999-06-04 Hyperforin-derivate, ihre verwendung sowie diese enthaltende zubereitungen
ES99926516T ES2249893T3 (es) 1998-06-10 1999-06-04 Derivados de hiperforina, uso de los mismos y formulados que los contienen.
IL14015199A IL140151A0 (en) 1998-06-10 1999-06-04 Hyperforin derivatives, the use thereof and formulations containing them
JP2000553398A JP4511726B2 (ja) 1998-06-10 1999-06-04 ハイパーフォリン誘導体、その利用及びこれを含む調剤
CA002334308A CA2334308C (en) 1998-06-10 1999-06-04 Hyperforin derivatives, the use thereof and formulations containing them
SK1871-2000A SK286049B6 (sk) 1998-06-10 1999-06-04 Hyperforínové deriváty, farmaceutický prostriedoks ich obsahom a ich použitie
EP05015870A EP1607099A1 (en) 1998-06-10 1999-06-04 Use of hyperforin derivatives as an antidepressant agent
MXPA00012177A MXPA00012177A (es) 1998-06-10 1999-06-04 Derivados de hiperforina, uso de los mismos y formulaciones que los contienen.
SI9930840T SI1086071T1 (sl) 1998-06-10 1999-06-04 Derivati hiperforina, njihova uporaba in farmacevtske oblike, ki jih vsebujejo
RU2000131214/04A RU2240304C2 (ru) 1998-06-10 1999-06-04 Производные гиперфорина, их использование и препараты, содержащие эти производные
CZ20004562A CZ298859B6 (cs) 1998-06-10 1999-06-04 Hyperforinové deriváty, jejich využití a prípravky je obsahující
BRPI9910893-3B1A BR9910893B1 (pt) 1998-06-10 1999-06-04 Derivados de hyperforin, seus usos, e formulações contendo os mesmos
CNB998071218A CN1246278C (zh) 1998-06-10 1999-06-04 贯叶金丝桃素衍生物,其用途及含有它们的组合物
DK99926516T DK1086071T3 (da) 1998-06-10 1999-06-04 Hyperforinforbindelser, anvendelse heraf og formuleringer indeholdende disse
AU43739/99A AU763889B2 (en) 1998-06-10 1999-06-04 Hyperforin derivatives, the use thereof and formulations containing them
PL99344696A PL195797B1 (pl) 1998-06-10 1999-06-04 Pochodne hiperforynowe, kompozycje farmaceutyczneje zawierające i zastosowanie tych pochodnych
PCT/EP1999/003880 WO1999064388A1 (en) 1998-06-10 1999-06-04 Hyperforin derivatives, the use thereof and formulations containing them
KR1020007013866A KR100627933B1 (ko) 1998-06-10 1999-06-04 하이퍼포린 유도체, 그의 용도 및 그를 함유한 제제
IL140151A IL140151A (en) 1998-06-10 2000-12-07 Hyperforin derivatives are used by Ben and the compositions containing them
NO20006230A NO328444B1 (no) 1998-06-10 2000-12-07 Hyperforinderivat, anvendelse derav og farmasoytisk sammensetning inneholdende det
US09/730,536 US6656510B2 (en) 1998-06-10 2000-12-07 Hyperforin derivatives, use thereof and formulations containing them
HK01107738A HK1036791A1 (en) 1998-06-10 2001-11-06 Hyperforin derivatives, the use thereof and formulations containing them

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1998MI001312A IT1301679B1 (it) 1998-06-10 1998-06-10 Derivati dell'iperforina, loro uso e formulazioni che licontengono.

Publications (2)

Publication Number Publication Date
ITMI981312A1 ITMI981312A1 (it) 1999-12-10
IT1301679B1 true IT1301679B1 (it) 2000-07-07

Family

ID=11380210

Family Applications (1)

Application Number Title Priority Date Filing Date
IT1998MI001312A IT1301679B1 (it) 1998-06-10 1998-06-10 Derivati dell'iperforina, loro uso e formulazioni che licontengono.

Country Status (23)

Country Link
US (1) US6656510B2 (it)
EP (2) EP1607099A1 (it)
JP (1) JP4511726B2 (it)
KR (1) KR100627933B1 (it)
CN (1) CN1246278C (it)
AT (1) ATE307103T1 (it)
AU (1) AU763889B2 (it)
BR (1) BR9910893B1 (it)
CA (1) CA2334308C (it)
CZ (1) CZ298859B6 (it)
DE (1) DE69927813T2 (it)
DK (1) DK1086071T3 (it)
ES (1) ES2249893T3 (it)
HK (1) HK1036791A1 (it)
HU (1) HUP0102226A3 (it)
IL (2) IL140151A0 (it)
IT (1) IT1301679B1 (it)
MX (1) MXPA00012177A (it)
NO (1) NO328444B1 (it)
PL (1) PL195797B1 (it)
RU (1) RU2240304C2 (it)
SK (1) SK286049B6 (it)
WO (1) WO1999064388A1 (it)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1770700A (en) * 1998-11-04 2000-05-22 Dr. Willmar Schwabe Gmbh & Co Stable preparations with hyperforin
ITMI20020871A1 (it) * 2002-04-23 2003-10-23 Indena Spa Derivati alogenati dell'iperforina loro uso e formulazioni che li contengono
ITMI20020872A1 (it) * 2002-04-23 2003-10-23 Indena Spa Derivati dell'iperforina loro uso e formulazioni che li contengono
US20060115556A1 (en) * 2004-12-01 2006-06-01 Foulger Sidney W Nutritional supplement drink containing xanthone extracts
US20060115555A1 (en) * 2004-12-01 2006-06-01 Foulger Sidney W Nutritional supplements containing xanthone extracts
BRPI0900614A2 (pt) 2009-02-13 2011-06-28 Univ Fed Do Rio Grande Do Sul Ufrgs extrato vegetal neuroativo, composição farmacêutica compreendendo o mesmo e processo para sua produção
MX2013014162A (es) 2011-06-03 2014-09-08 Harvard College Analogos de hiperforina, metodos de sintesis y usos de los mismos.
ITMI20131012A1 (it) 2013-06-19 2014-12-20 Indena Spa Derivati dell'iperforina e loro uso nella malattia di alzheimer
RU2676100C1 (ru) * 2018-10-05 2018-12-26 федеральное государственное автономное образовательное учреждение высшего образования "Санкт-Петербургский политехнический университет Петра Великого" (ФГАОУ ВО "СПбПУ") Применение производных пиперазина для лечения болезни Альцгеймера и деменций альцгеймеровского типа с нарушенной внутриклеточной кальциевой сигнализацией

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2550266A (en) * 1948-12-11 1951-04-24 Swift & Co Preservation of food products
DE4239959A1 (de) * 1992-11-27 1994-06-01 Schwabe Willmar Gmbh & Co Johanniskraut-Trockenextrakt, Verfahren zu seiner Herstellung und seine Verwendung
DE19646977A1 (de) * 1995-09-29 1998-01-15 Schwabe Willmar Gmbh & Co Stabiler Extrakt aus Hypericum perforatum L., Verfahren zu seiner Herstellung und pharmazeutische Zubereitungen
DE19714450A1 (de) * 1997-04-08 1998-10-15 Schwabe Willmar Gmbh & Co Stabiler Extrakt aus Hypericum perforatum L., Verfahren zu seiner Herstellung und pharmazeutische Zubereitung
CA2317671A1 (en) * 1998-01-13 1999-07-22 Rexall Sundown, Inc. St. john's wort and methyl donor composition and uses thereof
US6224906B1 (en) * 1999-08-31 2001-05-01 Natreon Inc. St. John's wort composition

Also Published As

Publication number Publication date
JP2002517478A (ja) 2002-06-18
IL140151A0 (en) 2002-02-10
NO20006230L (no) 2001-02-01
BR9910893A (pt) 2001-03-06
DK1086071T3 (da) 2006-01-23
US6656510B2 (en) 2003-12-02
PL344696A1 (en) 2001-11-19
CN1246278C (zh) 2006-03-22
HUP0102226A3 (en) 2003-07-28
MXPA00012177A (es) 2004-09-06
SK18712000A3 (sk) 2001-06-11
ES2249893T3 (es) 2006-04-01
CZ298859B6 (cs) 2008-02-27
KR100627933B1 (ko) 2006-09-22
SK286049B6 (sk) 2008-01-07
DE69927813D1 (de) 2006-03-02
CA2334308A1 (en) 1999-12-16
DE69927813T2 (de) 2006-04-20
IL140151A (en) 2006-12-10
HUP0102226A2 (hu) 2001-10-28
EP1086071B1 (en) 2005-10-19
ATE307103T1 (de) 2005-11-15
RU2240304C2 (ru) 2004-11-20
AU4373999A (en) 1999-12-30
BR9910893B1 (pt) 2013-10-29
CZ20004562A3 (en) 2001-06-13
NO20006230D0 (no) 2000-12-07
US20010020040A1 (en) 2001-09-06
AU763889B2 (en) 2003-07-31
JP4511726B2 (ja) 2010-07-28
HK1036791A1 (en) 2002-01-18
CN1304397A (zh) 2001-07-18
CA2334308C (en) 2009-06-02
PL195797B1 (pl) 2007-10-31
KR20010052637A (ko) 2001-06-25
WO1999064388A1 (en) 1999-12-16
EP1607099A1 (en) 2005-12-21
EP1086071A1 (en) 2001-03-28
ITMI981312A1 (it) 1999-12-10
NO328444B1 (no) 2010-02-22

Similar Documents

Publication Publication Date Title
CO4930259A1 (es) Derivados 6,6-heterobiciclicos sustituidos y composiciones farmaceuticas que los contienen
BR0111639A (pt) Uso de uma molécula de ácido oligodeoxinucléico, e composição farmacêutica contendo a mesma
BRPI0414539A (pt) composto, composição farmacêutica, e, uso de um composto
EE04799B1 (et) Ühendid, mis on kasulikud põletikuvastaste vahenditena, nende ühendite valmistamise meetodid ja neid sisaldavad farmatseutilised kompositsioonid
ES2134755T3 (es) Derivados de quinolina como antagonistas de leucotrieno d4, composiciones que contienen los mismos y procedimientos para su preparacion.
DE69907977D1 (de) Pyrrolobenzodiazepine
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
DK0889876T3 (da) Meta-substituerede phenylensulfonamidderivater
CY1106076T1 (el) Παραγωγα γλυκοπυρανοσυλοξυβενζυλο βενζολιου και ιατρικες συνθεσεις που πepιεχουν τα ιδια
MA26848A1 (fr) Derives d'heterocyclo-alkylsufonylpyrazole nouveaux servant d'agents anti-inflammatoires/analgesiques.
ES2174298T3 (es) Derivados de aminotiazol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
DE3860201D1 (de) Entzuendungshemmende agentien.
IT1301679B1 (it) Derivati dell'iperforina, loro uso e formulazioni che licontengono.
EA199801028A1 (ru) Применение производных п-аминофенола для проготовления фармацевтических композиций, используемых при лечении нейродегенеративных заболеваний
NO306116B1 (no) Ny benzotiadiazinforbindelse og farmasöytiske sammensetninger
DE50101861D1 (de) Tocotrienolchinon- zyklisierungsprodukte mit antihypercholesterin wirkung
PT870761E (pt) Derivados de tiocolchicina com actividades anti-inflamatoria e relaxante muscular
BR0114380A (pt) Derivados-1-aminobutan-3-ol-substituìdos
BR9814495A (pt) Composto, processo para prepará-lo, uso do mesmo, composição farmacêutica, e, processo
ES2179857T3 (es) Derivados de quinoleina sustituidos, procedimiento para su preparacion y su utilizacion.
ES2182090T3 (es) Nuevos derivados de pirrol.
RS50033B (sr) Derivati etansulfonil-piperidina
DE69600231D1 (de) N-Arylalkylphenylacetamidderivate
AR023374A1 (es) Derivados de 3-amino-3-arilpropano-1-ol. su preparacion y uso
AR021616A1 (es) Cicloheptenos sustituidos, procedimiento para su preparacion y uso de los mismos.

Legal Events

Date Code Title Description
0001 Granted